Showing 1,321 - 1,340 results of 1,871 for search 'Fenian~', query time: 1.93s Refine Results
  1. 1321

    Real World Evaluation of Next-Day Molecular Respiratory Infectious Disease Testing on Healthcare Resource Utilization and Costs by French AJ, Fragala MS, Evans AS, Upadhyay P, Goldberg SE, Reddy J

    Published 2025-02-01
    “…The PCR test cohort had lower total healthcare costs (mean = &dollar;5,601±&dollar;29,170, median = &dollar;807) versus the no test cohort (mean = &dollar;7,460±&dollar;40,817, median = &dollar;1,163) (p = 0.0014) over 6 months, and fewer outpatient visits, other medical service visits, emergency room visits, and inpatient stays (p< 0.0001). …”
    Get full text
    Article
  2. 1322

    Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice by V. V. Petkau, A. V. Sultanbaev, K. V. Menshikov, A. S. Antipin, M. V. Volkonsky, V. M. Filippova, Yu. V. Vasilyeva, A. A. Tarkhanov, M. R. Mukhitova, M. Zh. Murzalina, A. R. Safarova

    Published 2022-12-01
    “…The objective response rate (ORR), disease control rate (DCR), median overall survival (OS) and median progression-free survival (PFS) rates were assessed. …”
    Get full text
    Article
  3. 1323

    Estimating the impact of school closures on the COVID-19 dynamics in 74 countries: A modelling analysis. by Romain Ragonnet, Angus E Hughes, David S Shipman, Michael T Meehan, Alec S Henderson, Guillaume Briffoteaux, Nouredine Melab, Daniel Tuyttens, Emma S McBryde, James M Trauer

    Published 2025-01-01
    “…They reduced peak hospital occupancy pressure in nearly all countries, with 72 out of 74 countries (97%) showing a positive median estimated effect, and median estimated effect ranging from reducing peak hospital occupancy pressure by 89% in Brazil to increasing it by 19% in Indonesia. …”
    Get full text
    Article
  4. 1324
  5. 1325

    Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia by Yu Zhang, Zhao Yin, Zurong Yao, Dan Xu, Xuejie Jiang, Xiaqi Nie, Dandan Chen, Hongsheng Zhou, Pengcheng Shi, Hui Liu, Qifa Liu, Guopan Yu

    Published 2025-02-01
    “…In contrast, the CLAG group had a median OS of 18.6 (95% CI 14.7–22.6) months and EFS of 10.7 (95% CI 6.6–14.8) months. …”
    Get full text
    Article
  6. 1326

    Surget et Ambula: Literatura e (des)construção da nação by Remo Mutzenberg, Eliane Veras

    Published 2015-01-01
    “…Entrevista com Francisco Noa por Eliane Veras e Remo Mutzenberg…”
    Get full text
    Article
  7. 1327

    Cross-sectional analysis of two social determinants of health in California cities: racial/ethnic and geographic disparities by Dulce Bustamante-Zamora, Neil Maizlish

    Published 2017-06-01
    “…For education, median within-city difference was 26.6% for Latinos compared with Whites. …”
    Get full text
    Article
  8. 1328
  9. 1329

    Renal transplant recipient and deceased-donor risk profiles at Wits Donald Gordon Medical Centre, Johannesburg, South Africa: A 9-year review by F van der Schyff, M Barnard, B Ströbele, M de Jager, R Britz, P Gaylard, J Loveland

    Published 2024-04-01
    “…Similarly, the median UK KDRI was 0.9 (0.8 - 1.2). Both these scores performed poorly in predicting graft and patient survival, with a C-statistic of 0.5. …”
    Get full text
    Article
  10. 1330

    A Study on the Line of Sight to Galaxies Detected at Gamma-Ray Energies by Amy Furniss, Josepf N. Amador, Olivier Hervet, Ollie Jackson, David A. Williams

    Published 2025-01-01
    “…A similar comparison of the voidiness for LAT-detected AGN shows median p -values greater than 0.05 in each redshift interval. …”
    Get full text
    Article
  11. 1331

    Outcome of Excision with Primary Midline Closure for Sacrococcygeal Pilonidal Sinus Disease by Bahzad Waso Hamad

    Published 2020-12-01
    “…Thirty six patients with median age 22 years (range 14-40) with 24/12 male /female ratio. …”
    Get full text
    Article
  12. 1332
  13. 1333

    Assessment of priorities, quality, and inclusivity of digital therapeutics trials in China by Ziming Wang, Xinxin Xia, Weijia Lu, Yuguo Ye, Jin Xu

    Published 2025-02-01
    “…Mental, behavioral, or neurodevelopmental disorders represented the leading condition category of focus. Recent declines in median sample size, median duration, and mean number of sites were noted. …”
    Get full text
    Article
  14. 1334

    Attitudes of healthcare workers at a District in KwaZulu-Natal regarding institutionalisation of antimicrobial stewardship by Andile P. Dlungele, Lehlohonolo J. Mathibe

    Published 2025-01-01
    “…Eighty percent (n = 40; median score 5, interquartile range [IQR] 4–5) and 67% (n = 33; median score 4, IQR 3–4) of participants felt that they had a key role in reducing antibiotic resistance; and good knowledge of antimicrobials as well as AMS programmes, respectively. …”
    Get full text
    Article
  15. 1335
  16. 1336

    Long-term outcomes of drainless anatomical lung resection surgery for pulmonary malignancies by Ting-Fang Kuo, Mong-Wei Lin, Ke-Cheng Chen, Shuenn-Wen Kuo, Pei-Ming Huang, Jang-Ming Lee

    Published 2025-02-01
    “…The median lymph node dissection stations was four, and the number was 17. …”
    Get full text
    Article
  17. 1337

    Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas by Elise A. Chong, Elicia Penuel, Ellen B. Napier, Rachel K. Lundberg, Lihua E. Budde, Mazyar Shadman, Matthew J. Matasar, Nancy L. Bartlett, Ian W. Flinn, Francesc Bosch, Keith Fay, Andre Goy, Anita Kumar, Loretta J. Nastoupil, Michael C. Wei, Mei Wu, Shen Yin, Joseph A. Fraietta, Emeline R. Chong, Stephen J. Schuster

    Published 2025-02-01
    “…Additionally, responding patients had an increase in activated CD8 cells (median fold change, 1.7; P = .02). Nonresponders had a relative decrease in CAR transgene levels (n = 16; P = .04). …”
    Get full text
    Article
  18. 1338

    Scopus Indexing Delays of Articles Published in Major Pharmacy Practice Journals by Samuel Adeosun

    Published 2024-11-01
    “…The Kaplan-Meier curves were also significantly different; with median survival time of indexing in Scopus and PubMed being 4 and 2 weeks, respectively. …”
    Get full text
    Article
  19. 1339

    Liver Transplantation in Situs Inversus and Portal Vein Thrombosis (First Case Report in Russia) by M. S. Novruzbekov, O. D. Olisov, V. A. Guliaev, K. N. Lutsyk, K. M. Magomedov, B. I. Kazymov

    Published 2020-09-01
    “…Situs inversus is a rare mirror transposition of internal organs relative to the median plane. Liver transplantation in situs inversus is a serious medical challenge imposed by an abnormal arrangement of the recipient's organs.Aim. …”
    Get full text
    Article
  20. 1340

    Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States by Ehab L. Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, Carmine Rossi, Annie Guérin, Eric Q. Wu, Pallavi Patwardhan

    Published 2022-08-01
    “…Among 53 Medicare-insured patients with 3L+ (median age, 72.0 years; female, 39.6%), the median duration of 1L, 2L, and 3L therapy was 9.7, 5.0, and 7.0 months, respectively. …”
    Get full text
    Article